{"id":31879,"date":"2025-05-13T12:48:09","date_gmt":"2025-05-13T10:48:09","guid":{"rendered":"https:\/\/inmuno.es\/index.php\/2025\/05\/13\/correction-a-novel-disease-modifying-antirheumatic-drug-iguratimod-ameliorates-murine-arthritis-by-blocking-il-17-signaling-distinct-from-methotrexate-and-leflunomide\/"},"modified":"2025-05-13T12:48:09","modified_gmt":"2025-05-13T10:48:09","slug":"correction-a-novel-disease-modifying-antirheumatic-drug-iguratimod-ameliorates-murine-arthritis-by-blocking-il-17-signaling-distinct-from-methotrexate-and-leflunomide","status":"publish","type":"post","link":"https:\/\/inmuno.es\/index.php\/2025\/05\/13\/correction-a-novel-disease-modifying-antirheumatic-drug-iguratimod-ameliorates-murine-arthritis-by-blocking-il-17-signaling-distinct-from-methotrexate-and-leflunomide\/","title":{"rendered":"Correction: A Novel Disease-Modifying Antirheumatic Drug, Iguratimod, Ameliorates Murine Arthritis by Blocking IL-17 Signaling, Distinct from Methotrexate and Leflunomide"},"content":{"rendered":"<div>\n<p><b>J Immunol<\/b>. 2025 May 12:vkaf113. doi: 10.1093\/jimmun\/vkaf113. Online ahead of print.<\/p>\n<p><b>NO ABSTRACT<\/b><\/p>\n<p>PMID:<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40356078\/?utm_source=WordPress&amp;utm_medium=rss&amp;utm_content=2985117R&amp;ff=20250513064802&amp;v=2.18.0.post9+e462414\">40356078<\/a> | DOI:<a href=\"https:\/\/doi.org\/10.1093\/jimmun\/vkaf113\">10.1093\/jimmun\/vkaf113<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>J Immunol. 2025 May 12:vkaf113. doi: 10.1093\/jimmun\/vkaf113. Online ahead of print. NO ABSTRACT PMID:40356078 | DOI:10.1093\/jimmun\/vkaf113<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,71],"tags":[],"class_list":["post-31879","post","type-post","status-publish","format-standard","hentry","category-publicaciones","category-the-journal-of-immunology"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/31879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=31879"}],"version-history":[{"count":0,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/31879\/revisions"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=31879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/categories?post=31879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/tags?post=31879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}